Intrinsic Value of S&P & Nasdaq Contact Us

Lexaria Bioscience Corp. LEXX

NASDAQ Capital Marke

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+47.1%

Lexaria Bioscience Corp. (LEXX) current share price is $1.02. The gold spot price is $4,825.20 per troy ounce. Using the formula: LEXX in gold = $1.02 × 31.1035 ÷ $4,825.20 = 0.0066 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of LEXX when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding LEXX shares over the measured period.

LEXX in US Dollars
Gold in US Dollars
LEXX in Gold (grams per share)

Real Wealth Growth Rate

LEXX
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{LEXX}_{\text{gold}}(t) = \frac{P_{\text{LEXX}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{LEXX}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{LEXX}_{\text{gold}}^{(T)}}{\text{LEXX}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{LEXX}_\text{gold}^{(0)}$ = initial gold-price, $\text{LEXX}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

IMMX
IMMX
Immix Biopharma, Inc.
$9.85
+1.65%
ZURA
ZURA
Zura Bio Limited
$5.72
+0.70%
PHIO
PHIO
Phio Pharmaceuticals Corp.
$1.29
+4.03%
ICU
ICU
SeaStar Medical Holding Corporation
$3.75
-10.93%
SONN
SONN
Sonnet BioTherapeutics Holdings, Inc.
$1.26
-59.35%
RNAZ
RNAZ
TransCode Therapeutics, Inc.
$8.90
+1.14%
REVB
REVB
Revelation Biosciences, Inc.
$1.20
+0.84%
ZVSA
ZVSA
ZyVersa Therapeutics, Inc.
$0.19
-8.57%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message